Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Clinical trials have demonstrated varying degrees of weight loss depending on the specific agent and dosage: semaglutide 2.4mg (Wegovy) produces approximately 15% weight loss at 68 weeks, liraglutide 3mg (Saxenda) typically achieves 5-8% weight loss, while tirzepatide has shown up to 20% weight reduction in obesity trials
BioMe data is available through a process described at Pseudonymized data and/or biological samples can be accessed for research and development purposes in accordance with the Estonian Human Genome Research Act
We dont know which of the many effects of these drugs is really helping with obesity
Use in Pregnancy Semaglutide has not been testing in pregnant women
Switching from Mounjaro to Wegovy Why Hundreds Are Switching in 2025 From September 2025, the monthly cost of Mounjaro (tirzepatide) will rise to 160320 per pen, compared to the significantly lower prices at launch
Without proper nutrition and consistent strength training, individuals may experience a reduction in lean muscle mass alongside body fat
